DermConsult

Guest: Andrew Mastro, MS, PA-C Despite advances in targeted topical therapies for atopic dermatitis, significant gaps remain in treatment access and options for patients at both ends of the age spectrum. Join Andrew Mastro, physician assistant at the Illinois Dermatology Institute and DeNova Research in Chicago, as he explores the challenges of treating infants and older adults, barriers to access...

Guest: Andrew Mastro, MS, PA-C In atopic dermatitis, the timing of itch relief and visible skin improvement can make all the difference in how patients perceive their response to topical JAK inhibitor therapy. Andrew Mastro, physician assistant at the Illinois Dermatology Institute and DeNova Research in Chicago, shares his approach to translating clinical trial data into practical counseling stra...

Guest: Mariam Iqneibi, MD Persistent itching in children with atopic dermatitis can disrupt sleep, impair quality of life, and contribute to recurring flares. Join Dr. Mariam Iqneibi as she discusses practical strategies for breaking the itch-scratch cycle through effective inflammation control, proactive maintenance therapy, and gentle skincare. She's a pediatric dermatologist at Cincinnati Child...

Guest: Mariam Iqneibi, MD For kids with atopic dermatitis, the itch-scratch cycle can perpetuate inflammation, damage the skin barrier, and significantly impact quality of life. Join Dr. Mariam Iqneibi, pediatric dermatologist at Cincinnati Children's Hospital and Assistant Professor of Dermatology at the University of Cincinnati College of Medicine, as she explores the mechanisms driving the itch...

Guest: Andrew Mastro, MS, PA-C For patients with atopic dermatitis, how can we balance rapid symptom relief with long-term skin barrier protection? Join Andrew Mastro, physician assistant at the Illinois Dermatology Institute and DeNova Research in Chicago, as he shares his approach to sequencing topical corticosteroids and nonsteroidal therapies, including when short-term bridging strategies may...

Host: Mary Leuchars, MD Clear eczema education can be challenging, particularly when patients and caregivers are navigating complex treatment instructions and symptom monitoring. Hear about how visual tools could improve patient outcomes as Dr. Mary Leuchars explains findings from the Patient Eczema Education Pictorial Study (PEEPS) pilot study.

Host: Shelina Ramnarine, PhD Guest: Firas George Hougeir, MD, FAAD Chronic hand eczema can be difficult to characterize and manage. Subtypes may overlap, triggers can take time to identify, and different inflammatory pathways may be at play, all while patients continue to experience burdensome symptoms. Join Dr. Shelina Ramnarine and Dr. Firas George Hougeir as they examine how recognizing chronic...

Guest: Henry Yu, PA-C Chronic hand eczema (CHE) involves a complex interplay of inflammatory pathways that can influence treatment selection and response. To learn more, we recently spoke with dermatology surgical physician assistant Mr. Henry Yu. He explores the heterogeneous pathophysiology of CHE and how our understanding of the underlying inflammatory mechanisms can help us move beyond broad t...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Christina Kraus, MD Guest: Jill Krapf, MD Vulvar lichen sclerosus sits at the intersection of dermatology and gynecology, making coordinated care essential. In this expert-led conversation, Dr. Charles Turck sits down with Dr. Christina Kraus and Dr. Jill Krapf to hear their perspectives on working through diagnostic and therapeutic challenges and ap...

Host: Shelina Ramnarine, PhD Guest: Christopher Bunick, MD, PhD, FAAD Hand atopic dermatitis and other subtypes of chronic hand eczema can present similarly, but differences in their underlying drivers can have important implications for diagnosis and treatment. Review which clinical clues can point to hand atopic dermatitis, why underlying immune drivers matter, and how an accurate diagnosis can...

Host: Alexandria May, PharmD, BCPS Guest: Naiem T. Issa, MD, PhD, FAAD Guest: Allison Truong, MD Atopic dermatitis affecting the face, neck, hands, genital, and intertriginous areas can have a profound impact on patients' quality of life, even when overall disease involvement appears limited. Dr. Alexandria May sits down with Dr. Naiem Issa and Dr. Allison Truong as they share their perspectives o...

Host: Alexandria May, PharmD, BCPS Guest: Naiem T. Issa, MD, PhD, FAAD Inflammatory dermatoses don't always follow the rules. When clinical features overlap or presentations fall outside familiar patterns, reaching the right diagnosis requires a thoughtful, systematic approach. In this discussion with Dr. Alexandria May, Dr. Naiem Issa shares practical strategies for evaluating challenging cases a...

Guest: Peter Lio, MD Atopic dermatitis may look similar across patients, but could distinct underlying mechanisms call for more personalized treatment approaches? Dr. Peter Lio explores how emerging biomarkers could help us better understand individual disease drivers, guide treatment selection, and move individualized atopic dermatitis care closer to clinical practice. Dr. Lio is a Clinical Assis...

Guest: Peter Lio, MD As targeted therapies for atopic dermatitis continue to advance, expectations for treatment success are evolving. Dr. Peter Lio, Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, explores how clinicians can look beyond incremental improvement toward more ambitious goals, including sustained itch control, clear or...

Guest: Lawrence F. Eichenfield, MD Pediatric atopic dermatitis is associated with a range of comorbidities, and it's important to understand how they intersect. That's why Dr. Lawrence Eichenfield joins us to explain how we should consider conditions like food allergy, asthma, anxiety and depression, urticaria, and alopecia areata in these patients. Dr. Eichenfield is a Distinguished Professor of...

Guest: Brian S. Kim, MD Advances in our understanding of itch biology are reshaping how we approach atopic dermatitis, with therapies targeting the interface between the immune and nervous systems becoming central in effectively alleviating itch. Join Dr. Brian Kim as he examines current treatment strategies, explains the continued importance of helping patients recognize and manage triggers and f...

Guest: Tina Bhutani, MD, MAS Treatment success starts with understanding what matters to the patient, but in generalized pustular psoriasis (GPP), patient satisfaction alone may not be enough. Dr. Tina Bhutani joins us to share how she balances patients’ perspectives with the need for adequate disease control. She's an Associate Adjunct Professor of Dermatology at the University of California San...

Guest: Tina Bhutani, MD, MAS Generalized pustular psoriasis (GPP) is a dermatologic emergency that can progress rapidly and lead to serious complications. Dr. Tina Bhutani joins us to explain why prompt recognition and treatment are critical for limiting potentially life-threatening consequences. Dr. Bhutani is an Associate Adjunct Professor of Dermatology at the University of California San Franc...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: David Cotter, MD, PhD For patients experiencing an acute flare of generalized pustular psoriasis (GPP), rapid recognition can make all the difference. Join Dr. Charles Turck and Dr. David Cotter, a dermatologist at Las Vegas Dermatology, as they discuss practical approaches for managing these flares and supporting patients throughout their care.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: David Cotter, MD, PhD What role does IL-36 signaling play in generalized pustular psoriasis (GPP) and why is it an emerging focus in neutrophilic inflammatory disease? Join Dr. Charles Turck and Dr. David Cotter, a dermatologist at Las Vegas Dermatology, as they explore the genetic and acquired mechanisms underlying IL-36 dysregulation, the pathways...

Faculty: Tina Bhutani, MD, MAS Generalized pustular psoriasis (GPP) can progress rapidly, making prompt and effective treatment essential. In this episode, Dr. Tina Bhutani discusses the evolution of GPP management and the key factors that guide treatment decisions, including the need for rapid disease control, patient safety, and comorbidity management. She's an Associate Adjunct Professor of Der...

Guest: Shannon Trotter, DO, FAOCD, FAAD In generalized pustular psoriasis (GPP) management, earlier recognition is just the beginning. Find out what's next for patient care as Dr. Shannon Trotter discusses clinical and research priorities that could reshape our approach, including expanding evidence for dual therapy in patients with coexisting plaque psoriasis and the evolving role of genetics in...

Guest: Shannon Trotter, DO, FAOCD, FAAD Generalized pustular psoriasis (GPP) extends beyond acute flares, with the chronic phase often carrying a significant physical, emotional, and psychosocial burden. In this episode, Dr. Shannon Trotter explores how individualized treatment strategies that account for patient goals, lifestyle, and fear of future flares can help support disease control and impr...

Guest: Shannon Trotter, DO, FAOCD, FAAD When we only view generalized pustular psoriasis (GPP) as an acute dermatologic emergency, we might miss opportunities for earlier recognition. Dr. Shannon Trotter, Clinical Assistant Professor at Ohio University and principal investigator for clinical trials at DOCS Dermatology Group in Ohio, joins us to examine the disease's full clinical spectrum, review...

Guest: Shannon Trotter, DO, FAOCD, FAAD What clinical findings should prompt suspicion for generalized pustular psoriasis (GPP)? Find out as Dr. Shannon Trotter explores the evolving clinical presentation of GPP, from the often-overlooked pre-pustular phase to acute flares and post-flare disease. She also discusses the cutaneous and extracutaneous manifestations that can improve recognition, suppo...